A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants
Clinical trial NCT05093790 · COMPLETED
Trial details
- NCT number
- NCT05093790
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2022-11-14
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.